Infographic: FDA gains authority to prescribe less, but opioid prescriptions decreasing

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/	SARINYAPINNGAM)
(Image: Getty/ SARINYAPINNGAM)

Related tags: Opioid, Opioid epidemic, overdose

President Donald Trump signed the SUPPORT Act granting the FDA additional authority to combat the opioid epidemic, but a pain management CRO argues that opioid addiction isn't the only crisis.

After the SUPPORT Act was signed into legislation, Lynn Webster, VP of Scientific Affairs and Neuroscience at PRA Health Sciences, a clinical contract research organization (CRO), stated the new legislation has its shortcomings. 

One of the shortcomings, according to Webster, is that despite a continual decline in opioid prescription over the past several years, the legislation grants the FDA the ability to reduce the overall number of opioids in circulation. 

"There is a disconnect between the ​amount of prescribed opioids and the number of drug overdoses,"​ said Webster who believes the root cause of the drug crisis is complex and was not fully addressed by the legislation. 

Related news

Show more

Related products

show more

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us

Products

View more

Webinars